Salmon Calcitonin Completed Phase 2 Trials for Osteoporosis Basic Science

IndicationsStatusPurposePhase
CompletedBasic Science2
clinicaltrials.gov IdentifierTitleDrugs
NCT00620854A Dose Selection Study of Oral Recombinant Salmon Calcitonin (rsCT) in Normal, Healthy, Postmenopausal Women